Top Story

Liver cancer screening did not reduce mortality in cirrhosis cases

August 16, 2018
FDA News

FDA approves Lenvima for unresectable hepatocellular carcinoma

August 16, 2018
The FDA approved lenvatinib capsules for the first-line treatment of patients with unresectable hepatocellular carcinoma. The FDA based this approval of lenvatinib…
In the Journals Plus

Ibrutinib active, safe in Waldenström’s macroglobulinemia

August 16, 2018
Ibrutinib demonstrated activity and appeared safe among treatment-naive patients with Waldenström’s macroglobulinemia, study data showed…
Meeting NewsVideo

3 take-aways on payment models at GI Outlook 2018

August 16, 2018
AUSTIN, Texas — In this exclusive video perspective from GI Outlook 2018, Colleen M. Schmitt, MD, MHS, FASGE, president of the Galen Medical Group in Chattanooga…
In the Journals Plus

Rare Hodgkin lymphoma subtype has good prognosis after relapse

August 16, 2018
Salvage approaches led to favorable prognosis among patients with relapsed or refractory nodular lymphocyte-predominant Hodgkin lymphoma, according to study findings…
More Headlines »

Multimodality Treatment Strategies for NSCLC: A Symposium at the US Oncology Annual Meeting

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. Approximately 85% of diagnosed lung cancers are non-small…
More »
Meeting News

VIDEO: Telemedicine viable option for patients seeking efficient ways to receive health care

August 15, 2018
More »
Resource Centers
Immuno-Oncology Resource Center

Immuno-Oncology Resource Center


Ace the Case: A 48-Year-Old Woman Confused About a Diagnosis of Leukemia

There is no commercial support for this activity.

This “Ace the Case” activity will utilize a case study to discuss the assessment and management of a 48-year-old woman…
More »
Current Issues
View the Current Issue
HemOnc Today